ANAPTYSBIO
AnaptysBio is a privately-held therapeutic antibody product company that uses of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease. The Company's SHM-Platform utilizes the key components of SHM and other techniques to generate antibodies for therapeutic applications through an iterative process of natural evolution and high-throughput selection a process that has been referred to as naturali... zing antibodies. This versatile platform can be used both to discover and optimize antibodies directed at specific disease targets and also affinity mature existing antibodies to improve their binding properties. In addition to providing a more powerful approach to antibody discovery and protein optimization, it addresses a growing void in the therapeutic antibody field due to a string of acquisitions and licensing deals that have reduced the availability of many technologies.
ANAPTYSBIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.anaptysbio.com
Total Employee:
51+
Status:
Active
Contact:
(858) 362-6295
Total Funding:
85.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Domain Not Resolving Wordpress Plugins Sitelinks Search Box
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Allakos
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Ophidion
Ophidion is a biotechnology company that delivers a central nervous system therapeutics to targeted sites in the brain.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series D - AnaptysBio
Biotechnology Value Fund
Biotechnology Value Fund investment in Series D - AnaptysBio
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series D - AnaptysBio
BioMed Ventures
BioMed Ventures investment in Series D - AnaptysBio
Cormorant Asset Management
Cormorant Asset Management investment in Series D - AnaptysBio
Novo Holdings
Novo Holdings investment in Series B - AnaptysBio
Avalon Ventures
Avalon Ventures investment in Series B - AnaptysBio
Alloy Ventures
Alloy Ventures investment in Series B - AnaptysBio
Numenor Ventures
Numenor Ventures investment in Series B - AnaptysBio
WS Investments
WS Investments investment in Series B - AnaptysBio
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-31 | AnaptysBio Appoints Paul Lizzul as Its Chief Medical Officer |
Official Site Inspections
http://www.anaptysbio.com Semrush global rank: 2.58 M Semrush visits lastest month: 6.81 K
Unable to get host informations!!!
More informations about "AnaptysBio"
About - AnaptysBio
Enable broad development of our best-in-class programs targeting co-inhibitory receptors in RA and UC.. Generate in vitro and in vivo translational and clinical data to inform the potential …See details»
AnaptysBio - Crunchbase Company Profile & Funding
AnaptysBio is a privately-held therapeutic antibody product company that uses of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM …See details»
AnaptysBio, Inc. (ANAB) Company Profile & Facts - Yahoo Finance
See the company profile for AnaptysBio, Inc. (ANAB) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
AnaptysBio - The Org
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation. Industries. …See details»
AnaptysBio - Contacts, Employees, Board Members, Advisors
AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation. New. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
AnaptysBio, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for AnaptysBio, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
AnaptysBio (LON:0HFQ) Company Profile & Description - Stock …
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, …See details»
Orphanet: ANAPTYSBIO, INC.
Apr 9, 2025 AnaptysBio, Inc. AnaptysBio, Inc. 10770 Wateridge Circle, Suite 210 92121-5801 SAN DIEGO CA UNITED STATES. Phone 1: +1 (858) 362-6295. Contact email: …See details»
AnaptysBio - LinkedIn
AnaptysBio Biotechnology Research San Diego, California 10,527 followers Transforming patient health by delivering innovative immunology therapeutics.See details»
Contact - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 . Phone: (858) 362-6295 [email protected]See details»
AnaptysBio, Inc. - VentureRadar
AnaptysBio is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates to patients. We are focused on emerging immune control …See details»
Anaptys Announces First Quarter 2025 Financial Results and …
Mar 31, 2025 SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology …See details»
AnaptysBio Inc Company Profile - Overview - GlobalData
AnaptysBio Inc (Anaptys) is a clinical-stage biotechnology company. It is focused on advancing immune cell-modulating antibodies for autoimmune and inflammatory diseases. The …See details»
AnaptysBio - Funding, Financials, Valuation & Investors - Crunchbase
AnaptysBio is registered under the ticker NASDAQ:ANAB . Their stock opened with $15.00 in its Jan 26, 2017 IPO. Stock Symbol NASDAQ:ANAB ; Valuation at IPO $287M; Money Raised at …See details»
AnaptysBio - Products, Competitors, Financials, Employees, …
AnaptysBio's headquarters is located at 10770 Wateridge Circle, San Diego. What is AnaptysBio's latest funding round? ... VGXI is a contract development and manufacturing organization …See details»
AnaptysBio Company Profile - Office Locations, Competitors
Oct 29, 2024 AnaptysBio has 5 employees across 2 locations and $91.28 m in annual revenue in FY 2024. See insights on AnaptysBio including office locations, competitors, revenue, …See details»
AnaptysBio Company Overview, Contact Details & Competitors
Aug 14, 2024 SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology …See details»
Anaptys Announces First Quarter 2025 Financial Results and
2 days ago AnaptysBio, Inc. Consolidated Statements of Operations and Comprehensive Loss(in thousands, except per share data)(unaudited) Three Months Ended March 31,: 2025 …See details»
Pipeline - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 (858) 362-6295 (ph) [email protected]See details»
AnaptysBio | The Pharmaletter
AnaptysBio's preclinical immune cell modulator portfolio includes ANB033, an anti-CD122 antagonist antibody for the treatment of autoimmune and inflammatory diseases. In addition, …See details»